One challenge for innovators at MSK and elsewhere is that technology development is costly and funding options are limited—especially once the potential for federal grant funding has been exhausted.
Alliant Techsystems has received a $10.4M technology development contract to reduce the risk to develop a non-toxic Liquid Oxygen (LOx)-Liquid Methane rocket engine that could be used on future Crew ...